Notably, to reduce the risk of hypoglycemia caused by insulin administration and realize self-regulation, the microneedles are made glucose-responsive, relying on chemical-reaction-induced disassembly of insulin complex [49, 92]. The gene discussed is INS; the disease is Hypoglycemia.